Wen Rui-Ting, Wang Bin, Chen Hu
Academy of Military Medicine, Academy of Military Sciences, Beijing 100850, China,Department of Hematopoietic Stem Cell Transplantation, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th Hospital of PLA), Beijing 100071, China,Beijing Key Laboratory of Stem Cell Therapy and Transformation Research, Beijing 100071, China.
Department of Hematopoietic Stem Cell Transplantation, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th Hospital of PLA), Beijing 100071, China,Beijing Key Laboratory of Stem Cell Therapy and Transformation Research, Beijing 100071, China,E-mail:
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2020 Jun;28(3):1038-1043. doi: 10.19746/j.cnki.issn.1009-2137.2020.03.053.
Abstract Hematopoietic stem cells (HSCs), as a kind of adult stem cell, is first used in clinical practice. It has been widely used in hematopoietic stem cell transplantation and has broad application prospects in the field of gene therapy. However, the shortage of HSC is still the main bottleneck restricting the clinical application of HSC transplantation, especially cord blood HSC transplantation. With the continuous improvement of the concept of HSC and the in-depth study of the molecular mechanism regulating HSC self-renewal and differentiation, it have been explored that a variety of strategies for ex vivo expansion of HSC, such as adding small molecule compounds in vitro culture system, simulating bone marrow microenvironment, regulating HSC metabolism and biomaterial-based amplification methods. In this review, recent advances in research of ex vivo expansion strategy of HSC are summarized and discussed.
摘要 造血干细胞(HSCs)作为一种成体干细胞,最早应用于临床实践。它已广泛应用于造血干细胞移植,并在基因治疗领域具有广阔的应用前景。然而,造血干细胞的短缺仍然是限制造血干细胞移植临床应用的主要瓶颈,尤其是脐带血造血干细胞移植。随着造血干细胞概念的不断完善以及对调控造血干细胞自我更新和分化分子机制的深入研究,人们探索了多种造血干细胞体外扩增策略,如在体外培养体系中添加小分子化合物、模拟骨髓微环境、调节造血干细胞代谢以及基于生物材料的扩增方法。在本综述中,总结并讨论了造血干细胞体外扩增策略的最新研究进展。